SERA SERA PROGNOSTICS, INC.

Nasdaq Services-Medical Laboratories DE CIK: 0001534969
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

SERA is a pre-revenue/near-zero revenue company burning approximately $8.8M in cash quarterly with only $4.2M in cash reserves, implying less than 2 months of operational runway. Despite a healthy balance sheet with $67.6M equity and minimal debt, the company's fundamental inability to generate meaningful revenue combined with massive operating losses creates an imminent solvency crisis requiring immediate capital infusion or business transformation.

Strengths

  • + Zero financial leverage (no long-term debt; Debt/Equity 0.00x)
  • + Positive stockholders' equity of $67.6M provides theoretical liquidation cushion
  • + Loss metrics trending positively YoY (net loss improved 2.9% despite lack of scale)

Risks

  • ! Catastrophic cash runway: $4.2M cash versus $8.8M quarterly cash burn implies insolvency within 6 weeks
  • ! Negligible revenue generation ($14K quarterly) fails to offset any operating costs; unsustainable business model
  • ! 21 Form 4 filings in 90 days suggests elevated insider activity, potentially indicating management awareness of distress and opportunistic selling
  • ! Operating losses of $9.4M on $14K revenue demonstrates complete absence of path to profitability
  • ! Imminent capital raise requirement will create severe shareholder dilution

Key Metrics to Watch

Financial Metrics

Revenue
14.0K
Net Income
-8.4M
EPS (Diluted)
$-0.17
Free Cash Flow
-8.8M
Total Assets
93.5M
Cash
4.2M

Profitability Ratios

Gross Margin N/A
Operating Margin -66,857.1%
Net Margin -59,992.9%
ROE -12.4%
ROA -9.0%
FCF Margin -62,728.6%

Balance Sheet & Liquidity

Current Ratio
2.12x
Quick Ratio
2.12x
Debt/Equity
0.00x
Debt/Assets
27.7%
Interest Coverage
-4,680.00x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-08T12:18:42.351986 | Data as of: 2026-03-31 | Powered by Claude AI